Barclays analyst Raimo Lenschow lowered the firm’s price target on Oracle to $147 from $150 and keeps an Overweight rating on the shares following the fiscal Q1 report. The long-term story for Oracle “got stronger in Q1” with better cloud revenue, strong deferred revenue and artificial intelligence backlog commentary, the analyst tells investors in a research note. However, licenses have tough compares, Cerner is in software-as-a-service transition and shares were already up a lot recently, so net/net the Q1 report “doesn’t look like a short term catalyst,” says the firm.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ORCL: